Skip to content

Dr. DANAU WIM: what changed

BE 0867.529.891NACE 86.220, Specialist medical practiceOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€167,266
2024 · €226,898-€59,632
Equity
€1.3m
2024 · €1.4m-€21,156
Cash
€1.5m
2024 · €1.5m-€39,774
Balance sheet total
€1.8m
2024 · €2.0m-€145,761

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets -€109,363

    down €109,363 (-26.3%), from €415,389 to €306,026

    of which Land and buildings: -€76,985

  • Cash -€39,774

    down €39,774 (-2.6%), from €1.5m to €1.5m

    mainly Contributions, distributions and other (-€188,422) and Other debts (-€95,258)

Equity and liabilities
  • Other debts -€95,258

    down €95,258 (-16.2%), from €589,685 to €494,427

  • Tax, wage and social debts -€32,145

    down €32,145 (-90.3%), from €35,593 to €3,448

    of which Taxes: -€32,944

  • Reserves -€21,156

    down €21,156 (-1.6%), from €1.3m to €1.3m

    of which Distributable reserves: -€21,156

Income statement
  • Gross operating margin -€74,555

    down €74,555 (-16.3%), from €456,294 to €381,739

  • Taxes -€25,810

    down €25,810 (-24.3%), from €106,293 to €80,483

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €226,898
Gross operating margin -€74,555
Depreciation -€3,856
Financial income -€3,080
Financial charges -€3,951
Taxes +€25,810
Result 2025 €167,266
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€167,877
Investment -€19,229
Financing -€188,422
Cash 2024 €1.5m
Net result for the year +€167,266
Depreciation +€128,592
Receivables within one year -€3,070
Deferred charges and accrued income -€306
Trade debts +€2,798
Tax, wage and social debts -€32,145
Other debts -€95,258
Investment in fixed assets (net) -€19,229
Contributions, distributions and other -€188,422
Cash 2025 €1.5m
brings cash intakes cash out
Every line side by side 38 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,979,661 €1,833,900 -€145,761 -7.4%
Fixed assets 21/28 €415,389 €306,026 -€109,363 -26.3%
Tangible fixed assets 22/27 €415,389 €306,026 -€109,363 -26.3%
Land and buildings 22 €280,092 €203,107 -€76,985 -27.5%
Plant, machinery and equipment 23 €980 €291 -€689 -70.3%
Furniture and vehicles 24 €134,317 €102,628 -€31,689 -23.6%
Current assets 29/58 €1,564,272 €1,527,874 -€36,398 -2.3%
Amounts receivable within one year 40/41 €29,806 €32,876 +€3,070 +10.3%
Trade receivables 40 €29,806 €29,806 = 0.0%
Other amounts receivable 41 - €3,070 +€3,070
Cash at bank and in hand 54/58 €1,533,148 €1,493,374 -€39,774 -2.6%
Deferred charges and accrued income 490/1 €1,318 €1,624 +€306 +23.2%
Total equity and liabilities 10/49 €1,979,661 €1,833,900 -€145,761 -7.4%
Equity 10/15 €1,354,383 €1,333,227 -€21,156 -1.6%
Contributions 10/11 €12,400 €12,400 = 0.0%
Reserves 13 €1,341,983 €1,320,827 -€21,156 -1.6%
Non-distributable reserves 130/1 €2,000 €2,000 = 0.0%
Reserves not available under the articles 1311 €2,000 €2,000 = 0.0%
Distributable reserves 133 €1,339,983 €1,318,827 -€21,156 -1.6%
Amounts payable 17/49 €625,278 €500,673 -€124,605 -19.9%
Amounts payable within one year 42/48 €625,278 €500,673 -€124,605 -19.9%
Trade debts 44 - €2,798 +€2,798
Suppliers 440/4 - €2,798 +€2,798
Taxes, remuneration and social security 45 €35,593 €3,448 -€32,145 -90.3%
Taxes 450/3 €32,944 - -€32,944
Remuneration and social security 454/9 €2,649 €3,448 +€799 +30.2%
Other amounts payable 47/48 €589,685 €494,427 -€95,258 -16.2%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €124,736 €128,592 +€3,856 +3.1%
Gross operating margin 9900 €456,294 €381,739 -€74,555 -16.3%
Operating profit (loss) 9901 €331,558 €253,147 -€78,411 -23.6%
Financial income 75/76B €3,164 €84 -€3,080 -97.3%
Recurring financial income 75 €3,164 €84 -€3,080 -97.3%
Financial charges 65/66B €1,531 €5,482 +€3,951 +258%
Recurring financial charges 65 €1,531 €5,482 +€3,951 +258%
Profit (loss) for the period before taxes 9903 €333,191 €247,749 -€85,442 -25.6%
Income taxes 67/77 €106,293 €80,483 -€25,810 -24.3%
Profit (loss) for the period 9904 €226,898 €167,266 -€59,632 -26.3%
Profit (loss) for the period to be appropriated 9905 €226,898 €167,266 -€59,632 -26.3%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€1.5m to €1.8m

Midpoint €1.6m · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Adjusted equity €1.3m
Capitalised earnings €1.6m to €2.3m
Indication €1.5m to €1.8m

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€1,333,227
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€1.3m

Capitalised earnings

net result for the year (9904)
2025
€167,266
2024
€226,898
2023
€284,687
2022
€202,557
2021
€257,386
Average result
€226,284
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€1.6m / €1.9m / €2.3m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 10 November 2026 via checked.be.